DAIICHI SANKYO COMPANY, LIMITED

DAIICHI SANKYO COMPANY, LIMITED

FY2023 Q3 Financial Results Presentation

January 31, 2024

Koji Ogawa
Executive Officer, Head of GlobalCorporate Planning & Management, CFO
Wataru Takasaki
Executive Officer, Head of R&D Division

PLAY LIST

from the beginning

FY2023 Q3 Financial Results Presentation
Forward-Looking Statements
1.FY2023 Q3 Financial Results
Overview of FY2023 Q3 Results
Revenue
Core Operating Profit
Profit Attributable to Owners of the Company
Revenue: Business Units (incl. Forex Impact)
Revenue: Major Products in Japan
2.FY2023 Forecast/ Annual Dividend
Revision to the forecast
Revision of Annual Dividend
3.Business Update
Revenue
Performance in Each Region (US, EU)
Performance in Each Region (Japan, ASCA)
Major Updates on Patent Disputes
Major Updates on Patent Disputes
Other Regional Initiatives
Meeting Information
4.R&D Update
5DXd ADCs Update
ENHERTU DESTINY-PanTumor02 study
Dato-DXd TROPION-Breast04 study
Dato-DXd TROPION-Breast05 study
HERTHENA-Lung01 study
HERTHENA-PanTumor01 study
I-DXd* IDeate-Lung02 study**
REJOICE-Ovarian01 study
Other clinical progresses and regulatory updates
Next Wave Update
VALENTINE-PTCL01 Primary Results
Approval of COVID-19 vaccine
Ph1b/2 study start
News Flow
FY2023, FY2024News Flow
5.Appendix
Major R&D Milestones (ENHERTU)
Major R&D Milestones (DatoDXd)
Major R&D Milestones
Major R&D Milestones (Next Wave)
Major R&D Pipeline: 5DXd ADCs
Major R&D Pipeline: Next Wave
@
Q&A
  • Q&A 1
  • Q&A 2
  • Q&A 3
  • Q&A 4
  • Q&A 5
FY2023 Q3 Financial Results Presentation
  • Back
  • Next

Download

  • Presentation File(PDF 1.6 MB)
  • Questionnaire Please answer the questionnair
  • Forward-Looking Statements
    System Requirements
GreenPower
link corporate communications